Stratos Wealth Partners, Ltd. Dexcom Inc Transaction History

Stratos Wealth Partners, Ltd.

$6.32 Billion
Q1 2025

A detailed history of Stratos Wealth Partners, Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 3,428 shares of DXCM stock, worth $294,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,428

Previous 2,583 32.71%

Holding current value

$294,122

Previous $200,000 17.0%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	BUY	$67.74 - $90.75 $57,240 - $76,683	845 Added 32.71%	3,428 $234,000
Q4 2024 Jan 27, 2025	BUY	$65.68 - $81.01 $169,651 - $209,248	2,583 New	2,583 $200,000
Q2 2024 Jul 24, 2024	SELL	$110.31 - $140.45 $4,743 - $6,039	-43 Reduced 1.58%	2,675 $303,000
Q1 2024 Apr 16, 2024	BUY	$114.22 - $140.1 $4,797 - $5,884	42 Added 1.57%	2,718 $376,000
Q4 2023 Jan 24, 2024	SELL	$75.49 - $124.16 $21,590 - $35,509	-286 Reduced 9.66%	2,676 $332,000
Q3 2023 Oct 24, 2023	BUY	$86.06 - $137.93 $27,367 - $43,861	318 Added 12.03%	2,962 $276,000
Q2 2023 Jul 18, 2023	SELL	$112.47 - $130.98 $102,010 - $118,798	-907 Reduced 25.54%	2,644 $339,000
Q1 2023 Apr 27, 2023	SELL	$104.0 - $122.92 $208,520 - $246,454	-2,005 Reduced 36.09%	3,551 $412,000
Q4 2022 Jan 19, 2023	SELL	$84.98 - $122.67 $31,102 - $44,897	-366 Reduced 6.18%	5,556 $0
Q3 2022 Oct 24, 2022	SELL	$76.35 - $94.18 $9,543 - $11,772	-125 Reduced 2.07%	5,922 $477,000
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $314,657 - $615,014	4,628 Added 326.15%	6,047 $451,000
Q1 2022 Apr 26, 2022	BUY	$94.08 - $130.2 $31,987 - $44,267	340 Added 31.51%	1,419 $726,000
Q4 2021 Jan 14, 2022	BUY	$129.87 - $162.82 $649 - $814	5 Added 0.47%	1,079 $579,000
Q3 2021 Oct 19, 2021	BUY	$106.71 - $143.18 $2,027 - $2,720	19 Added 1.8%	1,074 $587,000
Q2 2021 Jul 19, 2021	BUY	$80.99 - $107.93 $5,426 - $7,231	67 Added 6.78%	1,055 $450,000
Q1 2021 Apr 27, 2021	BUY	$84.79 - $104.74 $423 - $523	5 Added 0.51%	988 $355,000
Q4 2020 Jan 29, 2021	SELL	$78.0 - $104.5 $11,622 - $15,570	-149 Reduced 13.16%	983 $363,000
Q3 2020 Oct 29, 2020	BUY	$95.51 - $112.95 $9,455 - $11,182	99 Added 9.58%	1,132 $467,000
Q2 2020 Jul 28, 2020	BUY	$62.68 - $105.34 $3,196 - $5,372	51 Added 5.19%	1,033 $419,000
Q1 2020 May 04, 2020	BUY	$47.79 - $75.63 $2,341 - $3,705	49 Added 5.25%	982 $264,000
Q4 2019 Jan 29, 2020	BUY	$36.62 - $57.29 $34,166 - $53,451	933 New	933 $204,000
Q4 2018 Feb 08, 2019	SELL	$26.99 - $37.37 $23,454 - $32,474	-869 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$23.35 - $36.72 $20,291 - $31,909	869 New	869 $124,000
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $19,627 - $28,221	-1,119 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$13.06 - $18.54 $2,572 - $3,652	-197 Reduced 14.97%	1,119 $83,000
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $14,633 - $20,240	1,316	1,316 $76,000

Others Institutions Holding DXCM

# of Institutions

1,083

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Dexcom Inc Transaction History